Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

40%

2 of 5 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

Phase 1

3(60.0%)

Phase 4

1(20.0%)

Phase 2

1(20.0%)

5Total

Phase 1(3)

Phase 4(1)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT01840956Phase 1Completed

Safety and Efficacy of a Vascular Prosthesis for Hemodialysis Access in Patients With End-Stage Renal Disease

Role: collaborator

NCT01937767Phase 2Completed

Remimazolam Phase II Cardiac Anesthesia Study

Role: collaborator

NCT00596752Phase 4Completed

Alprostadil in Peripheral Arterial Occlusive Disease (PAOD) Stage IV

Role: collaborator

NCT01097668Phase 1Completed

ATX-MS-1467 in Patients With Relapsing Forms of Multiple Sclerosis

Role: collaborator

NCT01874028Phase 1Completed

A Phase 1 Study to Assess the Effects in the Body of a Single Dose of Trientine Dihydrochloride in Wilson's Disease Patients

Role: collaborator

NCT01573026Unknown

Five Year Survival Study Evaluating the Genesis Dental Implant System

Role: collaborator

All 6 trials loaded